载血管内皮生长因子的生物可吸收递送系统用于牙髓再生的表征
本研究开发了一种直径50 μm、载血管内皮生长因子(VEGF)浓度为12.2 ng/cm的聚二氧环己酮纤维递送系统。体外实验显示该纤维对根尖乳头干细胞和小鼠成纤维细胞无细胞毒性,且能诱导多种生长因子表达;体内植入小鼠及人牙根片段后表现出生物相容性,促进根管内新生血管和结缔组织形成,炎症轻微。
要点
- 载VEGF聚二氧环己酮纤维直径50 μm,VEGF线性浓度12.2 ng/cm。
- 体外对根尖乳头干细胞和小鼠成纤维细胞无细胞毒性。
- 体内植入促进根管内新生血管和结缔组织形成,炎症轻微。
核心结论
- 本研究所用载VEGF纤维具有生物相容性,可能是一种有前景的支架,可用于牙髓再生操作的进一步优化和应用。
研究设计与样本
- 体外研究结合小鼠皮下植入实验:制备直径50 μm、载VEGF浓度12.2 ng/cm的聚二氧环己酮纤维,评估其对根尖乳头干细胞和小鼠成纤维细胞的细胞毒性及mRNA表达,并观察C57BL/6小鼠皮下植入载VEGF纤维及填充该纤维的人牙根片段(长10 mm)后10、20、45天的反应。
主要发现
- 酶联免疫吸附试验证实释放的VEGF在溶液中可检测浓度持续25天。
- 载VEGF纤维对根尖乳头干细胞和小鼠成纤维细胞未观察到细胞毒性。
- VEGF处理诱导了参与组织和血管形成及神经保护功能的其他生长因子表达。
- 植入载VEGF纤维及填充该纤维的牙根片段显示体内生物相容性,促进新生血管和结缔组织长入根管空间,炎症可忽略。
临床怎么用
- 作者认为本研究所用载VEGF纤维具有生物相容性,可能是有前景的支架,可用于牙髓再生操作的进一步优化和应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vascular endothelial growth factor (VEGF) is a signal protein that stimulates angiogenesis and vasculogenesis and has been used in tissue regeneration and pulp regeneration experimental models. The purpose of this study was to develop a delivery system composed of a biodegradable fiber and controlled release of VEGF to promote cell viability and secure an adequate blood supply for the survival of human stem cells of the apical papilla (SCAP) favoring endodontic regenerative procedures. METHODS: We developed a polydioxanone fiber, 50 μm in diameter, loaded with VEGF at a linear concentration of 12.2 ng/cm. Cytotoxic effects of the VEGF-loaded fiber (VF) on SCAP and mouse fibroblasts were assessed by using a multiparametric assay kit (XTT-NR-CVDE [Xenometrix, Allschwil, Switzerland]). We evaluated VF-induced mRNA expression of downstream growth factors by using a human growth factor Taqman array in real-time polymerase chain reaction. We also assessed the in vivo subcutaneous reaction of C57BL/6 mice to implants of VF alone and human root fragments (10 mm in length) filled with VF after 10, 20, and 45 days. Statistical analyses were performed by using analysis of variance and Student t tests or non-parametric alternatives. RESULTS: Enzyme-linked immunosorbent assay verified detectable concentrations of released VEGF in solution for 25 days. No cytotoxicity was observed on SCAP and mouse fibroblasts treated with VEGF. In addition, VEGF treatment also induced the expression of additional growth factors with roles in tissue and blood vessel formation and neuroprotective function. Implantation of VF and root fragments filled with VF showed biocompatibility in vivo, promoting new blood vessels and connective tissue formation into the root canal space with negligible inflammation. CONCLUSIONS: Our results show that the VF used in this study is biocompatible and may be a promising scaffold for additional optimization and use in endodontic regenerative procedures.
引用
- Yadlapati M, Biguetti C, Cavalla F, et al. Characterization of a Vascular Endothelial Growth Factor-loaded Bioresorbable Delivery System for Pulp Regeneration. J Endod. 2016. PMID: 27939739. doi:10.1016/j.joen.2016.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。